Hypoparathyroidism and Pseudo-hypoparathyroidism
نویسندگان
چکیده
منابع مشابه
Cerebro-metacarpo-metatarsal Dystrophy (pseudo-pseudo Hypoparathyroidism) with Chromosomal Anomaly.
Albright, Burnett, Smith, and Parson (I942) investigated a female patient of 28 years who had suffered from idiopathic epilepsy since the age of I2. Because the bones of the skull were unusually dense, hypoparathyroidism was suspected. The diagnosis was made when it was found that her Chwostek sign was positive and that her serum calcium and phosphorus levels were 6-4 and 6o mg. per I00 ml. res...
متن کاملNormocalcaemic Hypoparathyroidism
Objective There are no consistent data on the prevalence and bone status of normocalcaemic hypoparathyroidism (NHYPO) as defined by normal adjusted calcium and low PTH level. Our aim was to determine the prevalence and the metabolic bone profile of NHYPO in older women, assessing its evolution over time. The second objective was to evaluate the prevalence of other calcium metabolic disorders. D...
متن کاملHypoparathyroidism and pseudohypoparathyroidism.
The principal function of the parathyroid hormone (PTH) is maintenance of calcium plasmatic levels, withdrawing the calcium from bone tissue, reabsorbing it from the glomerular filtrate, and indirectly increasing its intestinal absorption by stimulating active vitamin D (calcitriol) production. Additionally, the PTH prompts an increase in urinary excretion of phosphorus and bicarbonate, seeking...
متن کاملEpidemiology and Diagnosis of Hypoparathyroidism.
CONTEXT Hypoparathyroidism is a disorder characterized by hypocalcemia due to insufficient secretion of PTH. Pseudohypoparathyroidism is a less common disorder due to target organ resistance to PTH. This report summarizes the results of the findings and recommendations of the Working Group on Epidemiology and Diagnosis of Hypoparathyroidism. EVIDENCE ACQUISITION Each contributing author revie...
متن کاملHypoparathyroidism unmasked by alendronate.
The case of an elderly woman is reported in whom alendronate, given for osteoporosis, led to severe hypocalcaemia a few days after starting the drug treatment. This was caused by the unmasking of previously unrecognised hypoparathyroidism.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1954
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.4867.903